inlexzo 225 MG Intravesical System
- RxCUI
- 2723391
- RxNorm name
- inlexzo 225 MG Intravesical System
- Display name
- inlexzo 225 MG Intravesical System
- Full name
- inlexzo 225 MG Intravesical System
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:54
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INLEXZO | GEMCITABINE INTRAVESICAL | Janssen Biotech, Inc | 3aef8dbc-34d0-4150-89f0-3b16cf0fbfdb | 2025-09-11 | Warnings, Adverse reactions | 2723391 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 3aef8dbc-34d0-4150-89f0-3b16cf0fbfdb | inlexzo 225 MG Intravesical System | PSN | 1 | These highlights do not include all the information needed to use INLEXZO safely and effectively. See full prescribing information for INLEXZO. INLEXZO™ (gemcitabine intravesical system) Initial U.S. Approval: 2025 | 20250911 |
| 3aef8dbc-34d0-4150-89f0-3b16cf0fbfdb | gemcitabine 225 MG Drug Implant [Inlexzo] | SBD | 1 | These highlights do not include all the information needed to use INLEXZO safely and effectively. See full prescribing information for INLEXZO. INLEXZO™ (gemcitabine intravesical system) Initial U.S. Approval: 2025 | 20250911 |
| 3aef8dbc-34d0-4150-89f0-3b16cf0fbfdb | Inlexzo 225 MG Intravesical System | SY | 1 | These highlights do not include all the information needed to use INLEXZO safely and effectively. See full prescribing information for INLEXZO. INLEXZO™ (gemcitabine intravesical system) Initial U.S. Approval: 2025 | 20250911 |